Revolutionizing Esophageal Treatment: Biostage Launches Clinical Trial for Severe Disease
Biostage Advances Clinical Trial for Esophageal Diseases HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) — Biostage, Inc. (OTCQB: BSTG) Introduction Biostage, a leading biotechnology company, is making significant progress in the development of groundbreaking technology aimed at regenerating organs within the body to combat various severe illnesses. The company’s focus lies in treating diseases such…